R Factory |China R Manufacturers, Suppliers

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Ruxolitinib

API Nomen Indicium Innovator Exitus patentibus Date (US)

Ruxolitinib Myelofibrosis Novartis 6, 2024

inquisitionis detail
Relugolix

API Nomen Indicium Innovator Exitus patentibus Date (US)

Relugolix cancer prostatae Takeda et Aska 24 Jan

inquisitionis detail
Rimegepant

API Nomen Indicium Innovator Exitus patentibus Date (US)

Rimegepant Migraine capitis Biohaven 22 Dec

inquisitionis detail
Relugolix 737789-87-6

API Nomen Indicium Specification US DMF EU DMF CEP

Ribociclib CAS: 737789-87-6 Antineoplastic In-Domus

inquisitionis detail
Ribociclib 1374639-75-4

API Nomen Indicium Innovator Exitus patentibus Date (US)

Ribociclib 1374639-75-4 HR-positivum, HER2-negativum Andvance ormetastaticbreast Cancers Novartis
Pharmaceuticals Iun.27, 2028

inquisitionis detail
Rivaroxaban

API Nomen Indicium Specification US DMF EU DMF CEP

Rivaroxaban Anticoagulant In-Domus TDP

inquisitionis detail
Rosuvastatin Calcium

API Nomen Indicium Specification US DMF EU DMF CEP

Rosuvastatin Calcium Hypercholesterolemia In-Domus/CEP 20705 CEP2015-240

inquisitionis detail